Coromandel International Approves Q1 Results; Considers Loan Conversions Worth Rs 108 Crores and USD 9.7 Million Restructuring
Coromandel International Limited has announced the approval of its unaudited financial results for the quarter ending June 30, 2026, following a Board meeting held on July 23, 2026. The Board also approved significant corporate actions relating to loan conversions and restructuring within its subsidiaries.The company’s Q1 performance details were reviewed by the Audit Committee and are available alongside a Limited Review Report issued by S R Batliboi & Associates LLP.
Key corporate decisions included the approval of converting a loan worth about Rs 108 Crores into equity shares of Coromandel Chemicals Limited, a subsidiary of the company. These conversion shares have a face value of Rs 10/- each and were approved at an issue price of Rs 39.95/- per equity share (including premium).
Furthermore, the Board approved the restructuring of a USD 9.70 Million loan provided to Baobab Mining and Chemicals Corporation S A (BMCC), a step-down subsidiary held through Coromandel Chemicals Limited. This restructuring will involve converting the debt into equity or preference shares or other instruments as mutually agreed upon by the parties.
Financial Performance Overview
The unaudited financial results for the quarter ended June 30, 2026, showed various figures across both standalone and consolidated entities.The Consolidated Results for Q1 ended June 30, 2026, stood as follows:
| Particulars | Q1 Ended June 30, 2026 (Consolidated) | Year Ended March 31, 2026 (Consolidated) |
|---|---|---|
| Total Income | 8,214.58 | 31,827.45 |
| Total Expenses | 7,700.90 | 29,139.69 |
| Profit before tax (7) | 513.68 | 2,687.70 |
| Net profit after tax attributable to Owners of the Company | 369.14 | 2,021.20 |
Segmental Performance Highlights
The company operates in two main segments: Nutrient and other allied business, and Crop protection. The segment results reflect the performance across different periods.The management reports that the revenue from operations for the quarter ended June 30, 2026, was Rs 7,743.55 Crores (Standalone). In terms of profit before tax, the standalone results stood at Rs 505.34.
A detailed look at the segment performance is provided below:
| Segment | Metric | Qtr Ended June 30, 2026 | Qtr Ended Mar 31, 2026 | Qtr Ended June 30, 2025 | Year Ended March 31, 2026 |
|---|---|---|---|---|---|
| Segment Revenue | Nutrient & other allied business | 6,910.49 | 4,70.83 | 6,311.11 | 27,692.87 |
| Crop protection | 870.08 | 715.16 | 724.19 | 3,053.60 | |
| Total Revenue | 7,780.57 | 5,685.99 | 7,035.60 | 30,746.47 | |
| Segment Profit before tax | Nutrient & other allied business | 469.88 | 223.30 | 636.68 | 2,473.64 |
| Crop protection | 158.81 | 137.94 | 110.64 | 568.80 |
Balance Sheet Segmental Data
The segment assets and liabilities as of June 30, 2026:Segment Assets (₹ in Crores)
| Business Segment | Nutrient & other allied business | Crop protection | Unallocable assets | Total Assets |
|---|---|---|---|---|
| As at June 30, 2026 | 18,947.86 | 3,688.40 | 2,734.21 | 25,370.47 |
Segment Liabilities (₹ in Crores)
| Business Segment | Nutrient & other allied business | Crop protection | Unallocable liabilities | Total Liabilities |
|---|---|---|---|---|
| As at June 30, 2026 | 11,133.39 | 1,026.09 | 367.97 | 12,527.45 |
COROMANDEL Stock Price Movement
Coromandel International Limited sheds value as the stock slips by 1.50%, trading at ₹2008.7 as of 2:35 PM in live market activity. The equity sees significant transactional volume, with 71,022 shares changing hands during current trading sessions.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.